Cargando…
Heart Rate Changes Following the Administration of Sugammadex to Infants and Children With Comorbid Cardiac, Cardiovascular, and Congenital Heart Diseases
BACKGROUND: Sugammadex is a novel, rapidly-acting pharmacologic agent to reverse steroidal neuromuscular blocking agents with demonstrated advantages over acetylcholinesterase inhibitors. However, anecdotal reports have noted rare instances of bradycardia and even cardiac arrest. The current study e...
Autores principales: | Arends, Jordan, Hubbard, Richard, Shafy, Shabana Z., Hakim, Mohammed, Kim, Stephani S., Tumin, Dmitry, Tobias, Joseph D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430884/ https://www.ncbi.nlm.nih.gov/pubmed/32849961 http://dx.doi.org/10.14740/cr1045 |
Ejemplares similares
-
Decrease in heart rate following the administration of sugammadex in adults
por: Sims, Trent, et al.
Publicado: (2020) -
Use of Sugammadex in a Patient With Myotonic Dystrophy
por: Ahmed, Samira, et al.
Publicado: (2018) -
Monitoring of Sugammadex Dosing at a Large Tertiary Care Pediatric Hospital
por: Syed, Faizaan, et al.
Publicado: (2018) -
Sleep-disordered breathing and reaction time in children
por: Hakim, Mohammed, et al.
Publicado: (2018) -
Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease
por: Goldstein, Sarah A., et al.
Publicado: (2020)